JP2018505262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018505262A5 JP2018505262A5 JP2017533536A JP2017533536A JP2018505262A5 JP 2018505262 A5 JP2018505262 A5 JP 2018505262A5 JP 2017533536 A JP2017533536 A JP 2017533536A JP 2017533536 A JP2017533536 A JP 2017533536A JP 2018505262 A5 JP2018505262 A5 JP 2018505262A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- potassium
- linked
- items
- linked polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims description 479
- 239000011591 potassium Substances 0.000 claims description 411
- 229910052700 potassium Inorganic materials 0.000 claims description 411
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 410
- 239000002245 particle Substances 0.000 claims description 180
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 130
- 238000004132 cross linking Methods 0.000 claims description 51
- 159000000007 calcium salts Chemical class 0.000 claims description 47
- 230000008961 swelling Effects 0.000 claims description 38
- 239000012798 spherical particle Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 description 69
- 239000000203 mixture Substances 0.000 description 60
- 239000008194 pharmaceutical composition Substances 0.000 description 51
- 125000000217 alkyl group Chemical group 0.000 description 39
- 150000003839 salts Chemical class 0.000 description 38
- 125000003118 aryl group Chemical group 0.000 description 25
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 18
- 239000004971 Cross linker Substances 0.000 description 11
- 208000002682 Hyperkalemia Diseases 0.000 description 11
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 10
- TUMCWFMHZOUPDA-UHFFFAOYSA-N 2-ethylsulfanyl-1,3-benzothiazol-6-amine Chemical compound C1=C(N)C=C2SC(SCC)=NC2=C1 TUMCWFMHZOUPDA-UHFFFAOYSA-N 0.000 description 9
- 239000004376 Sucralose Substances 0.000 description 9
- 229960004543 anhydrous citric acid Drugs 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 150000001721 carbon Chemical group 0.000 description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 9
- 235000019408 sucralose Nutrition 0.000 description 9
- 229910052736 halogen Inorganic materials 0.000 description 7
- 150000002367 halogens Chemical class 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 229960002796 polystyrene sulfonate Drugs 0.000 description 3
- 239000011970 polystyrene sulfonate Substances 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical group OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000002694 phosphate binding agent Substances 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462096447P | 2014-12-23 | 2014-12-23 | |
| US62/096,447 | 2014-12-23 | ||
| PCT/US2015/067460 WO2016111855A1 (en) | 2014-12-23 | 2015-12-22 | Compositions and methods for treating hyperkalemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020122933A Division JP7254748B2 (ja) | 2014-12-23 | 2020-07-17 | 高カリウム血症を処置するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018505262A JP2018505262A (ja) | 2018-02-22 |
| JP2018505262A5 true JP2018505262A5 (enExample) | 2019-02-07 |
| JP6821571B2 JP6821571B2 (ja) | 2021-01-27 |
Family
ID=55229846
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017533536A Active JP6821571B2 (ja) | 2014-12-23 | 2015-12-22 | 高カリウム血症を処置するための組成物および方法 |
| JP2020122933A Active JP7254748B2 (ja) | 2014-12-23 | 2020-07-17 | 高カリウム血症を処置するための組成物および方法 |
| JP2022205560A Pending JP2023027355A (ja) | 2014-12-23 | 2022-12-22 | 高カリウム血症を処置するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020122933A Active JP7254748B2 (ja) | 2014-12-23 | 2020-07-17 | 高カリウム血症を処置するための組成物および方法 |
| JP2022205560A Pending JP2023027355A (ja) | 2014-12-23 | 2022-12-22 | 高カリウム血症を処置するための組成物および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9655921B2 (enExample) |
| EP (1) | EP3236940B1 (enExample) |
| JP (3) | JP6821571B2 (enExample) |
| KR (1) | KR102674230B1 (enExample) |
| CN (1) | CN107406548B (enExample) |
| AR (1) | AR103250A1 (enExample) |
| AU (1) | AU2015375390B2 (enExample) |
| BR (1) | BR112017013264A2 (enExample) |
| CA (1) | CA2971725C (enExample) |
| ES (1) | ES2800167T3 (enExample) |
| IL (1) | IL252603A0 (enExample) |
| MX (1) | MX373216B (enExample) |
| NZ (1) | NZ732542A (enExample) |
| RU (1) | RU2017126229A (enExample) |
| TW (1) | TW201628631A (enExample) |
| WO (1) | WO2016111855A1 (enExample) |
| ZA (1) | ZA201703771B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9433640B2 (en) | 2014-12-23 | 2016-09-06 | Ardelyx, Inc. | Compositions and methods for treating hyperkalemia |
| CA2971725C (en) * | 2014-12-23 | 2024-05-14 | Ardelyx, Inc. | Compositions and methods for treating hyperkalemia |
| MX2020001412A (es) | 2017-08-04 | 2020-08-03 | Ardelyx Inc | Compuestos y métodos para tratar la hiperpotasemia. |
| ES3039169T3 (en) | 2019-02-07 | 2025-10-17 | Ardelyx Inc | Glycyrrhetinic acid derivatives for use in treating hyperkalemia |
| US12280144B2 (en) | 2019-12-19 | 2025-04-22 | Zaki Yusuf | Gel compositions for mitigation of burn injuries, kits containing the gel compositions, and associated methods |
| US20240139234A1 (en) * | 2021-11-17 | 2024-05-02 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Pharmaceutical polymer for treating hyperkalemia and preparation method thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3785864A (en) | 1970-07-23 | 1974-01-15 | Boehringer Mannheim Gmbh | Process for the chromatographic separation of multi-component mixtures containing glucose |
| GB1561395A (en) | 1976-02-26 | 1980-02-20 | Beecham Group Ltd | -lactam antibiotic |
| CA1166413A (en) | 1980-10-30 | 1984-05-01 | Edward E. Timm | Process and apparatus for preparing uniform size polymer beads |
| JPS57193414A (en) * | 1981-05-25 | 1982-11-27 | Sekisui Chem Co Ltd | Preparation of remedy for hypercalcemia |
| WO1999020285A1 (en) * | 1997-10-16 | 1999-04-29 | Sanwa Kagaku Kenkyusho Co., Ltd. | Gel preparations containing polystyrenesulfonate |
| US6280717B1 (en) * | 1998-07-31 | 2001-08-28 | Nikken Chemicals Co., Ltd. | Cation exchange resin preparation |
| JP3596742B2 (ja) * | 1998-07-31 | 2004-12-02 | 日研化学株式会社 | 陽イオン交換樹脂製剤 |
| US6270755B1 (en) * | 1999-05-13 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Anionic polymers as toxin binders |
| CA2557999C (en) * | 2004-03-30 | 2013-11-12 | Ilypsa, Inc. | Methods and compositions for treatment of ion imbalances |
| US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
| KR101269766B1 (ko) * | 2004-03-30 | 2013-05-30 | 리립사, 인크. | 이온 결합 중합체 및 이의 용도 |
| US20080081072A1 (en) * | 2006-09-30 | 2008-04-03 | Cherukuri S R | Resin-complex granulation for water-soluble drugs and associated methods |
| DE202007014890U1 (de) * | 2007-03-14 | 2008-04-17 | BLüCHER GMBH | Hochleistungsadsorbentien auf der Basis von Aktivkohle mit hoher Meso- und Makroporosität |
| EP3431094B1 (en) * | 2008-08-22 | 2022-12-07 | Vifor (International) Ltd. | Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
| US20100104527A1 (en) * | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
| US20110028412A1 (en) | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
| ES2364683B1 (es) | 2009-12-29 | 2012-08-08 | Bioibérica S.A. | Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares. |
| CA2824441A1 (en) * | 2011-01-10 | 2012-07-19 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation - binding polymers and calcium and/or magnesium cations, and uses thereof |
| TWI605837B (zh) | 2011-01-27 | 2017-11-21 | Kowa Co Ltd | Pharmaceutical composition containing water-insoluble drug and pharmaceutical preparation |
| ES2441468B1 (es) | 2012-08-03 | 2014-11-13 | Laboratorios Rubió, S.A. | Composición farmacéutica sólida de resina de intercambio catiónico. |
| ES2471340B1 (es) | 2012-12-21 | 2015-08-17 | Laboratorios Rubió, S.A. | Composición farmacéutica oral para fármacos de elevada posología |
| CA2971725C (en) * | 2014-12-23 | 2024-05-14 | Ardelyx, Inc. | Compositions and methods for treating hyperkalemia |
-
2015
- 2015-12-22 CA CA2971725A patent/CA2971725C/en active Active
- 2015-12-22 US US14/912,682 patent/US9655921B2/en active Active
- 2015-12-22 KR KR1020177019904A patent/KR102674230B1/ko active Active
- 2015-12-22 TW TW104143161A patent/TW201628631A/zh unknown
- 2015-12-22 AR ARP150104260A patent/AR103250A1/es unknown
- 2015-12-22 CN CN201580069983.7A patent/CN107406548B/zh active Active
- 2015-12-22 NZ NZ732542A patent/NZ732542A/en unknown
- 2015-12-22 AU AU2015375390A patent/AU2015375390B2/en active Active
- 2015-12-22 MX MX2017007603A patent/MX373216B/es active IP Right Grant
- 2015-12-22 BR BR112017013264-8A patent/BR112017013264A2/pt not_active Application Discontinuation
- 2015-12-22 JP JP2017533536A patent/JP6821571B2/ja active Active
- 2015-12-22 EP EP15828619.5A patent/EP3236940B1/en active Active
- 2015-12-22 WO PCT/US2015/067460 patent/WO2016111855A1/en not_active Ceased
- 2015-12-22 ES ES15828619T patent/ES2800167T3/es active Active
- 2015-12-22 RU RU2017126229A patent/RU2017126229A/ru unknown
-
2017
- 2017-04-14 US US15/487,967 patent/US20180064751A1/en not_active Abandoned
- 2017-06-01 IL IL252603A patent/IL252603A0/en unknown
- 2017-06-01 ZA ZA201703771A patent/ZA201703771B/en unknown
-
2020
- 2020-07-17 JP JP2020122933A patent/JP7254748B2/ja active Active
-
2022
- 2022-12-22 JP JP2022205560A patent/JP2023027355A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schubert et al. | Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms | |
| Pooresmaeil et al. | Surface modification of graphene oxide with stimuli-responsive polymer brush containing β-cyclodextrin as a pendant group: Preparation, characterization, and evaluation as controlled drug delivery agent | |
| Tian et al. | The classification and application of cyclodextrin polymers: a review | |
| AU2005231424B2 (en) | Ion binding polymers and uses thereof | |
| CN102597030B (zh) | 可植入的可生物吸收的聚合物 | |
| JP6078480B2 (ja) | 移植可能な膨潤性生体吸収性ポリマー | |
| Sun et al. | Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles | |
| JP2010507451A5 (enExample) | ||
| JP2007530737A5 (enExample) | ||
| CN101904818B (zh) | 自组装复合物膜控缓释制剂及其制备方法 | |
| JP6004449B2 (ja) | トリブロックコポリマー及びその使用 | |
| WO2003013552A1 (en) | Embolic materials comprising of chitin and/or chitosan and method for preparing thereof | |
| CN1980639A (zh) | 离子结合组合物 | |
| JP2016516072A5 (enExample) | ||
| CN103396521A (zh) | 两亲性β-环糊精星型聚合物的合成及其胶束化应用 | |
| JP6496252B2 (ja) | ポリカチオン性トリブロックコポリマーとポリアニオン性ポリマーの組成物を含む癒着防止用製剤 | |
| RU2017126229A (ru) | Композиции и способы лечения гиперкалиемии | |
| CN102702451A (zh) | 一种pH敏感且生物相容高效抗菌的聚合物胶束及其制备方法 | |
| AU2016216697B2 (en) | Ion binding polymers and uses thereof | |
| CN1128167C (zh) | 一种壳聚糖－聚丙烯酸复合物的纳米微球及其制法和用途 | |
| JP2013056909A5 (enExample) | ||
| CN104622813A (zh) | 一种基于主客体作用形成的纳米微球及其制法和用途 | |
| CN104292477A (zh) | 一种可自组装成纳米管的聚氨酯材料的制备方法、产品及应用 | |
| CN103980502B (zh) | 一种用作药物载体的聚合物囊泡及其制备方法和应用 | |
| CN115708891B (zh) | 一种基于微流控技术的显影载药微球及其制备方法和应用 |